Ta strona została przetłumaczona automatycznie i dokładność tłumaczenia nie jest gwarantowana. Proszę odnieść się do angielska wersja za tekst źródłowy.

Groceries dla mieszkańców południowo -wschodnich USA w celu zatrzymania nadciśnienia (GoFreshSE)

14 listopada 2026 zaktualizowane przez: Stephen Juraschek, Beth Israel Deaconess Medical Center

GoFreshSE is a randomized control trial, testing the effects of a home-delivered, dietitian-assisted, DASH-patterned grocery intervention on blood pressure in adults with high blood pressure in Florida, Georgia, and Tennessee.

Przegląd badań

Szczegółowy opis

Hypertension (HTN) affects half of US adults and is one of the most important modifiable risk factors for cardiovascular disease (CVD) and death.

The DASH diet is a proven strategy for lowering blood pressure in adults. Our proposed clinical trial will evaluate the effectiveness of a scalable solution: home-delivered, low-sodium groceries aligned with the DASH dietary pattern and ordered with dietitian assistance via a virtual supermarket, in reducing blood pressure.

Participants will be assigned to one of two 1-month long interventions: (1) dietitian-assisted, DASH-patterned, home-delivered groceries ordered weekly through Amazon Fresh (or Whole Foods) over 4 weeks or (2) self-directed grocery shopping (monthly stipend and DASH diet brochure) (referent).

Typ studiów

Interwencyjne

Zapisy (Szacowany)

150

Faza

  • Nie dotyczy

Kontakty i lokalizacje

Ta sekcja zawiera dane kontaktowe osób prowadzących badanie oraz informacje o tym, gdzie badanie jest przeprowadzane.

Lokalizacje studiów

    • Massachusetts
      • Boston, Massachusetts, Stany Zjednoczone, 02215
        • Beth Israel Deaconess Medical Center

Kryteria uczestnictwa

Badacze szukają osób, które pasują do określonego opisu, zwanego kryteriami kwalifikacyjnymi. Niektóre przykłady tych kryteriów to ogólny stan zdrowia danej osoby lub wcześniejsze leczenie.

Kryteria kwalifikacji

Wiek uprawniający do nauki

18 lat i starsze (Dorosły, Starszy dorosły)

Akceptuje zdrowych ochotników

Tak

Płeć kwalifikująca się do nauki

Wszystko

Opis

Inclusion Criteria:

  1. Resting systolic blood pressure of 120 to <160 mm Hg and diastolic blood pressure <110 mm Hg
  2. Resident of Florida, Georgia, and Tennessee
  3. Able to receive home-delivered groceries or pick them up at a convenient location and willing to eat only the groceries provided over a 4-week period
  4. Have access to refrigeration, cooking appliances, and Wi-Fi/cellular service
  5. Have access to mobile device or computer to be able to conduct grocery orders via video conference and send/receive text messages
  6. Willing and able to complete required measurement procedures
  7. Able to provide consent for the study
  8. Has access to a primary care team, urgent care center, or emergency room the study team can refer to for follow up care if warranted during the study

Exclusion Criteria:

A. Laboratory Exclusions:

  1. Serum potassium ≥5.4 mmol/L or <3.5 mmol/L
  2. Estimated glomerular filtration rate (eGFR) <30 mL/min per 1.73 m^2 by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation
  3. Hemoglobin A1c ≥6.5%

B. Medication Exclusions:

Unstable doses (i.e. a change in the 6 months prior to screening or randomization or planning to start within study period) of the following:

  1. GLP-1 and dual GLP-1/GIP receptor agonists
  2. Anti-hypertension medications
  3. Sodium-glucose co-transporter 2 (SGLT2) inhibitors
  4. Glucose lowering medications

Use of any of the following medications:

  1. Potassium supplement, except if part of a multivitamin
  2. Warfarin (Coumadin)
  3. Chronic oral corticosteroid (intermittent use is okay)
  4. Weight loss medications (non-GLP-1 receptor agonists)
  5. Sulfonylurea or any insulin use

Any medication not compatible with participation as determined by the investigators

C. Physical Exclusions:

  1. Systolic blood pressure: <120 or ≥160 mm Hg or diastolic blood pressure ≥110 mm Hg
  2. Arm circumference >52 cm (or the upper limit of the validated BP device)

D. Medical History Exclusions:

  1. Self-reported weight loss or gain of 15 pounds during prior 2 months
  2. Active cardiovascular disease or any event in the prior 6 months, including coronary artery bypass grafting (CABG), percutaneous transluminal coronary angioplasty (PTCA), myocardial infarction (MI), cerebrovascular accident (CVA), or congestive heart failure (CHF) exacerbation requiring hospital admission
  3. Cancer diagnosis or treatment in the last 2 years (non-melanoma skin cancer or localized breast or prostate or bladder cancer not requiring systemic therapy is acceptable)
  4. Gastrointestinal surgery or history that affects nutrition absorption or requires a specific diet that will deter DASH diet adherence
  5. Pregnancy or lactation or planned pregnancy during the study period
  6. Any emergency department (ED) visit for asthma or chronic obstructive pulmonary disease (COPD) in the last 6 months
  7. Hypoglycemia hospitalization in the last 12 months
  8. Any other serious illness or condition not compatible with participation as determined by the investigators

E. Lifestyle and Other Exclusions:

  1. Significant food allergies, preferences, intolerances, or dietary requirements that would interfere with diet adherence
  2. Consumption of more than 14 alcoholic drinks per week or consumption of more than 6 drinks on one or more occasion per week
  3. Active substance use disorder that would interfere with participation
  4. Extreme food insecurity
  5. Participation in or planning to start weight loss program
  6. Current participation in another clinical trial that could interfere with the study protocol
  7. Anticipated change in residence outside of eligible states prior to the end of the study
  8. Families with more than 6 adults at dinner time (children count as half an adult)

F. Investigator discretion

Plan studiów

Ta sekcja zawiera szczegółowe informacje na temat planu badania, w tym sposób zaprojektowania badania i jego pomiary.

Jak projektuje się badanie?

Szczegóły projektu

  • Główny cel: Leczenie
  • Przydział: Randomizowane
  • Model interwencyjny: Przydział równoległy
  • Maskowanie: Podwójnie

Broń i interwencje

Grupa uczestników / Arm
Interwencja / Leczenie
Eksperymentalny: Dietitian-Assisted DASH Groceries

Participants will order groceries sufficient to meet their caloric needs each week for 4 weeks with the assistance of a dietitian/nutrition interventionist. Groceries will be delivered to participants' homes or picked up at a convenient location. The dietitian/nutrition interventionist will provide brief educational content at the time of food delivery. Orders will be placed via phone or through virtual counseling sessions.

The DASH ("Dietary Approaches to Stop Hypertension"), is a healthy dietary pattern that lowers blood pressure without reducing weight. The DASH diet emphasizes fruits, vegetables, and low-fat dairy products; includes whole grains, poultry, fish, and nuts; and is reduced in red meat, sweets, and sugar-containing beverages.

Intervention Phase:

This intervention is a weekly, 4-week DASH dietary intervention. A dietitian will assist participants in ordering groceries in a pattern consistent with the DASH diet to be delivered to their homes. The quantity of groceries will be based on participant Calorie needs and family size.

Aktywny komparator: Self-directed shopping

Participants will receive a stipend and some basic information about healthy eating. The stipend is not restricted to foods.

Intervention Phase:

Participants will receive some basic information on healthy eating and a stipend during the 4-week intervention period. They are permitted to use the stipend however they choose and will not be asked about how they spent these funds.

Co mierzy badanie?

Podstawowe miary wyniku

Miara wyniku
Opis środka
Ramy czasowe
Self-measured systolic blood pressure
Ramy czasowe: Measured before and after the 4-week intervention

This entails 4 measurements, 2 in the morning and 2 in the evening, over a 7 day period (at least 3 concurrent days is acceptable for analysis).

Measured before and after the 4-week intervention

Miary wyników drugorzędnych

Miara wyniku
Opis środka
Ramy czasowe
Self-measured diastolic blood pressure
Ramy czasowe: Measured before and after the 4-week intervention

This entails 4 measurements, 2 in the morning and 2 in the evening, over a 7 day period (at least 3 concurrent days is acceptable for analysis).

Measured before and after the 4-week intervention
Seated systolic and diastolic blood pressure (technician-measured)
Ramy czasowe: Measured before and after the 4-week intervention

Seated systolic and diastolic blood pressure measured by a technician in participants' homes, using the office blood pressure device.

Measured before and after the 4-week intervention
Body Mass Index (BMI)
Ramy czasowe: Height is measured before the intervention. Weight is measured before and after the 4-week intervention.

At home measurement based on height and weight measured by a technician via a stadiometer and scale.

Height is measured before the intervention. Weight is measured before and after the 4-week intervention.
24-hour dietary recall
Ramy czasowe: Measured before and after the 4-week intervention

Assessed via self-administered questionnaire using the Automated Self-Administered 24-Hour Dietary Recall (ASA24).

Measured before and after the 4-week intervention
Spot urine sodium/potassium ratio
Ramy czasowe: Measured before and after the 4-week intervention

Measured in urine collected at the participants' homes.

Measured before and after the 4-week intervention
Lipids
Ramy czasowe: Measured before and after the 4-week intervention

Measured in fasted serum specimens collected during phlebotomy. Includes total cholesterol, high density lipoprotein cholesterol, derived low density lipoprotein cholesterol, and triglycerides

Measured before and after the 4-week intervention
Fasting glucose
Ramy czasowe: Measured before and after the 4-week intervention

Measured in blood as part of a basic metabolic panel

Measured before and after the 4-week intervention
Serum potassium
Ramy czasowe: Measured before and after the 4-week intervention

Measured in blood as part of a basic metabolic panel

Measured before and after the 4-week intervention

Inne miary wyników

Miara wyniku
Opis środka
Ramy czasowe
General Health Status
Ramy czasowe: Measured before and after the 4-week intervention

Single General Health Status Question: "Would you say that in general your health is excellent, very good, good, fair, or poor?"

Measured before and after the 4-week intervention
Financial strain
Ramy czasowe: Measured before and after the 4-week intervention

We will ask the following questions: How often does this describe you? I don't have money to pay my bills (including food, housing, medical care or heating).

Never / Rarely / Sometimes / Often / Always

Measured before and after the 4-week intervention

Współpracownicy i badacze

Tutaj znajdziesz osoby i organizacje zaangażowane w to badanie.

Daty zapisu na studia

Daty te śledzą postęp w przesyłaniu rekordów badań i podsumowań wyników do ClinicalTrials.gov. Zapisy badań i zgłoszone wyniki są przeglądane przez National Library of Medicine (NLM), aby upewnić się, że spełniają określone standardy kontroli jakości, zanim zostaną opublikowane na publicznej stronie internetowej.

Główne daty studiów

Rozpoczęcie studiów (Rzeczywisty)

14 października 2025

Zakończenie podstawowe (Szacowany)

1 listopada 2026

Ukończenie studiów (Szacowany)

1 grudnia 2026

Daty rejestracji na studia

Pierwszy przesłany

18 marca 2025

Pierwszy przesłany, który spełnia kryteria kontroli jakości

18 marca 2025

Pierwszy wysłany (Rzeczywisty)

24 marca 2025

Aktualizacje rekordów badań

Ostatnia wysłana aktualizacja (Rzeczywisty)

18 listopada 2026

Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości

14 listopada 2026

Ostatnia weryfikacja

1 listopada 2026

Więcej informacji

Terminy związane z tym badaniem

Inne numery identyfikacyjne badania

  • 2025P000102
  • GRT67144 (Inny numer grantu/finansowania: American Heart Association)

Plan dla danych uczestnika indywidualnego (IPD)

Planujesz udostępniać dane poszczególnych uczestników (IPD)?

TAK

Typ informacji pomocniczych dotyczących udostępniania IPD

  • PROTOKÓŁ BADANIA
  • SOK ROŚLINNY

Informacje o lekach i urządzeniach, dokumenty badawcze

Bada produkt leczniczy regulowany przez amerykańską FDA

Nie

Bada produkt urządzenia regulowany przez amerykańską FDA

Nie

Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .

Subskrybuj